How much funding has Arctic Therapeutics raised?

Arctic Therapeutics has raised $27.6M in total funding, most recently a Series A round.

Who are Arctic Therapeutics's investors?

Arctic Therapeutics's investors include European Innovation Council Fund.

When was Arctic Therapeutics founded?

Arctic Therapeutics was founded in 2015.

Where is Arctic Therapeutics headquartered?

Arctic Therapeutics is headquartered in Reykjavik.

What industry is Arctic Therapeutics in?

Arctic Therapeutics operates in Biotech.

Arctic Therapeutics

Reykjavik · Founded 2015 · $27.6M raised

Biotech

Headquarters: Reykjavik
Founded: 2015
Business Model: B2B
Website: arctictherapeutics.com

Total Funding: $27.6M
Last Round: $27.6M Series AJan 2025
Rounds: 1

About

Arctic Therapeutics is a clinical-stage biopharmaceutical company founded in 2015 by Dr. Hakon Hakonarson as a spin-off from the Center for Applied Genomics at Children's Hospital of Philadelphia. Using genetic sequencing and Iceland's national genealogy database, it develops treatments for rare and common forms of dementia, inflammatory skin diseases, and autoimmune disorders, combining internal discovery with academic and industry collaborations to bring therapies to patients faster.

Summary

Arctic Therapeutics is a Biotech company based in Reykjavik, founded in 2015. It has raised $27.6M in total across 1 round, most recently a $27.6M Series A round in Jan 2025. Investors include European Innovation Council Fund.